论文信息 - A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Therapy: - 字舞流文

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Therapy:

A. Naranjo | J. Maris | W. London | R. Seeger | M. Diccianni | A. Yu | K. Messer | B. Shulkin | M. Parisi | Julie R. Park | P. Sondel | C. Reynolds | F. Ozkaynak | A. Gilman | Sheena C. Tenney | L. Smith | Malcolm A. Smith